ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2025.13018 ETM-31-1-13018 Retraction [Retracted] Novel compound cedrelone inhibits hepatocellular carcinoma progression via PBLD and Ras/Rap1 WuJiansong NiuQiang YuanJie XuXiaodan CaoLiuxia 012026 17112025 31 1 23 Copyright: © 2025 Wu et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Exp Ther Med 18:4209–4220, 2019; DOI: 10.3892/etm.2019.8080

Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that the tumor images shown in Fig. 5A on p. 4218 were strikingly similar to data that had already appeared in different form in another article written by different authors at different research institutes, which was published in the journal OncoTarget.

In view of the fact that the abovementioned data had already apparently been published previously, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.